Scientists developed Evo 2, a large biological foundation model trained on about 9 trillion DNA base pairs that can analyse ...

Market Outlook and Growth TrajectoryThe global next generation sequencing market is poised to experience robust expansion, registering an estimated growth rate of around 15% over the next five years.

An artificial intelligence (AI) algorithm used to detect breast cancer in screening scans has been adapted into a risk score ...

Late in 2025, we covered the development of an AI system called Evo that was trained on massive numbers of bacterial genomes. So many that, when prompted with sequences from a cluster of related genes ...

The DNA foundation model Evo 2 has been published in the journal Nature. Trained on the DNA of over 100,000 species across ...

A new Australian artificial intelligence tool could transform breast cancer screening by offering a more personalised and ...

When the performance of AI models was assessed within stratified patient subgroups, such as only high-grade breast cancers or ...

Abstract: Temperature fluctuations can influence the stability of Deoxyribonucleic Acid (DNA), affecting recombination and mutation rates. Inspired by these biological mechanisms, we introduce a new ...

An estimated 170,000 Australians were diagnosed with cancer in 2025. Many people know the causes of cancer are partly genetic. But how do your genes, which contribute so much of what makes you you, ...

CRISPR gene drives bias inheritance in pests, advancing population-level control while raising questions about resistance and ...

LINE-1 retrotransposons are mobile genome parasites that drive cancer evolution by reshuffling the host genome.

A woman in her late 20s presented with a 5-year history of progressive fatigue and generalised weakness. Examination revealed signs of premature ageing, anaemia, neuropathy and hepatosplenomegaly.